Fundamental differences between the nucleic acid chaperone activities of HIV-1 nucleocapsid protein and Gag or Gag-derived proteins: biological implications

Virology. 2010 Sep 30;405(2):556-67. doi: 10.1016/j.virol.2010.06.042. Epub 2010 Jul 23.

Abstract

The HIV-1 Gag polyprotein precursor has multiple domains including nucleocapsid (NC). Although mature NC and NC embedded in Gag are nucleic acid chaperones (proteins that remodel nucleic acid structure), few studies include detailed analysis of the chaperone activity of partially processed Gag proteins and comparison with NC and Gag. Here we address this issue by using a reconstituted minus-strand transfer system. NC and NC-containing Gag proteins exhibited annealing and duplex destabilizing activities required for strand transfer. Surprisingly, unlike NC, with increasing concentrations, Gag proteins drastically inhibited the DNA elongation step. This result is consistent with "nucleic acid-driven multimerization" of Gag and the reported slow dissociation of Gag from bound nucleic acid, which prevent reverse transcriptase from traversing the template ("roadblock" mechanism). Our findings illustrate one reason why NC (and not Gag) has evolved as a critical cofactor in reverse transcription, a paradigm that might also extend to other retrovirus systems.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, N.I.H., Intramural
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Cell Line
  • DNA, Viral / metabolism*
  • Fluorescence Polarization
  • HIV-1 / genetics
  • HIV-1 / metabolism
  • HIV-1 / physiology
  • Humans
  • Molecular Chaperones / genetics
  • Molecular Chaperones / metabolism*
  • Nucleic Acid Conformation
  • Protein Multimerization
  • Reverse Transcription
  • gag Gene Products, Human Immunodeficiency Virus / genetics
  • gag Gene Products, Human Immunodeficiency Virus / metabolism*

Substances

  • DNA, Viral
  • Molecular Chaperones
  • NCP7 protein, Human immunodeficiency virus 1
  • gag Gene Products, Human Immunodeficiency Virus